273 related articles for article (PubMed ID: 7665988)
1. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
3. Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
Martinez-Navio JM; Climent N; Pacheco R; Garcia F; Plana M; Nomdedeu M; Oliva H; Rovira C; Miralles L; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
Immunology; 2009 Nov; 128(3):393-404. PubMed ID: 20067539
[TBL] [Abstract][Full Text] [Related]
4. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
5. Binding of adenosine deaminase to the lymphocyte surface via CD26.
De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
[TBL] [Abstract][Full Text] [Related]
6. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
Semnani RT; Nutman TB; Hochman P; Shaw S; van Seventer GA
J Exp Med; 1994 Dec; 180(6):2125-35. PubMed ID: 7525848
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
9. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
10. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
11. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
12. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets.
Willheim M; Ebner C; Baier K; Kern W; Schrattbauer K; Thien R; Kraft D; Breiteneder H; Reinisch W; Scheiner O
J Allergy Clin Immunol; 1997 Sep; 100(3):348-55. PubMed ID: 9314347
[TBL] [Abstract][Full Text] [Related]
13. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
[TBL] [Abstract][Full Text] [Related]
14. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18.
Tomura M; Maruo S; Mu J; Zhou XY; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Clark S; Kurimoto M; Fujiwara H
J Immunol; 1998 Apr; 160(8):3759-65. PubMed ID: 9558078
[TBL] [Abstract][Full Text] [Related]
15. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
Levesque MC; Haynes BF
J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
[TBL] [Abstract][Full Text] [Related]
16. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
17. The tumour associated cell surface antigen A6H is costimulatory for human CD4+ but not CD8+ T cells.
Labuda T; Parra E; Hedlund G; Kalland T; Dohlsten M
Immunology; 1997 Feb; 90(2):236-43. PubMed ID: 9135552
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
19. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
Sawchuk SS; Gates R; Hirsch R
Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
[TBL] [Abstract][Full Text] [Related]
20. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]